News By/Courtesy: Akansha Yadav | 15 Mar 2019 17:00pm IST

HIGHLIGHTS

  • The Union minister of State, health & family welfare, Ashwini Kumar Choubey in Mumbai released the “National Action Plan – Viral Hepatitis” and the National Guidelines for Hepatitis B.
  • According to WHO stats, 257 million people are living with chronic hepatitis B and 71 million with hepatitis C globally.
  • Hundreds of millions of people suffer from chronic diseases and the most common cause of liver cirrhosis and cancer due to types B and C.

The Union minister of State, health & family welfare, Ashwini Kumar Choubey in Mumbai released the “National Action Plan – Viral Hepatitis” and the National Guidelines for Hepatitis B. On 25th February 2019, the World Health Organization (WHO) and its Goodwill Ambassador for Hepatitis in South-East Asia Region Mr. Amitabh Bachchan, have inaugurated national action plan for viral hepatitis aiming to reach life-saving drugs and diagnostics to over 50 million affected people across the India.  Mr Bachchan who is himself a hepatitis B survivor has been passionately advocating for countries to prevent, test and treat hepatitis and while speaking at the release of India’s National Action for Viral Hepatitis stated that the course of discovery of hepatitis is important and if identified timely hepatitis it can be cured and called himself an example of that. At this occasion, Regional Director Dr Poonam Khetrapal Singh praising India on becoming the first country in WHO South-East Asia Region acclaimed its efforts as commendable.

Hepatitis viruses are the most common cause of hepatitis in the world, a disease which causes an inflammation of the liver which can lead to the condition that can be self-limiting or can progress to fibrosis (scarring), cirrhosis or liver cancer. There are 5 chief hepatitis viruses referred to as types A, B, C, D and E which are of the highest worry due to the burden of illness and death these hepatitis viruses cause and the potential for outbreaks and epidemic spread. Hundreds of millions of people suffer from chronic diseases and the most common cause of liver cirrhosis and cancer due to types B and C. Both types usually occur due to parenteral contact with infected body fluids.

According to WHO stats, 257 million people are living with chronic hepatitis B and 71 million with hepatitis C globally. And, 5% of 257 million and 3% of 71 million only have access to treatment. Twenty-one countries account for 75% of global hepatitis burden, almost 15% of which is in countries of WHO South-East Asia Region, mainly in India, Indonesia, Myanmar, Bangladesh and Thailand. Nearly 40,000 people die in the WHO South-East Asia Region every year The national action plan following launch of the National Viral Hepatitis programme released on the World Hepatitis day is in sync with the WHO’s regional and global action plans. The hepatitis programme aiming at comprehensively addressing – prevention, treatment and management of hepatitis A to E in India is expected to benefit an estimated 50 million people suffering from hepatitis - 40 million from hepatitis B, which is preventable, and over 10 million from hepatitis C, which can be cured.

Section Editor: Shreyashi Tiwari | 15 Mar 2019 17:05pm IST


Tags : #National #Viral #Hepatitis #Viral #Healthcare #Plan #Eradication

Latest News

























5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice

5thvoice


Copyright Kalyan Krishna MediaZ Private Limited. All rights reserved. Unless otherwise indicated, all materials on these pages are copyrighted by Kalyan Krishna MediaZ Private Limited. All rights reserved. No part of these pages, either text or image may be used for any purpose. By continuing past this page, you agree to our Terms of Service, Cookie Policy, Privacy Policy and Content Policies.